Goodrx Holdings Inc


Goodrx Holdings Inc

  • Price (USD)5.15
  • Today's Change-0.10 / -1.90%
  • Shares traded2.55m
  • 1 Year change-88.88%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

GoodRx Holdings, Inc. is a consumer-focused digital healthcare platform. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a range of different sources. The platform provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharma manufacturers provide affordability solutions such as co-pay cards, patient assistance programs, care portals and other savings options. Its prescription transactions offering provides curated, geographically relevant price comparisons and negotiated prices on prescriptions

  • Revenue in USD (TTM)803.49m
  • Net income in USD-47.11m
  • Incorporated2015
  • Employees756.00
  • Location
    Goodrx Holdings Inc2701 Olympic Boulevard, Suite 990SANTA MONICA 90404United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://investors.goodrx.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GDRX:NSQ since
VitaCare Prescription Services IncDeal completed07 Mar 202207 Mar 2022Deal completed-67.77%157.00m
Data delayed at least 15 minutes, as of Sep 23 2022 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
LegalZoom. com Inc608.09m-104.23m1.70bn1.22k--10.33--2.79-0.5279-0.52793.080.84481.73--50.97499,254.50-29.74---93.59--65.65---17.14-----8.790.00--22.19---1,604.42------
TechTarget Inc293.79m13.60m1.74bn1.00k178.937.2848.335.910.32880.32889.058.080.4584--5.88293,788.002.123.602.353.9873.9974.514.637.00--2.070.65590.0077.5419.83-94.44-17.0723.42--
CarGurus Inc1.50bn-122.99m1.77bn1.20k--3.8213.691.17-1.05-1.0512.683.901.68--10.231,250,286.0011.1916.6216.7921.6047.3685.496.6710.783.45--0.000.0072.5236.86-100.20--13.96--
Upwork Inc563.23m-80.43m1.79bn650.00--7.27--3.18-0.6224-0.62244.371.890.6773--8.53866,510.80-9.67-5.19-13.78-7.6973.2370.92-14.28-7.34---17.290.6956--34.5725.05-145.94--48.63--
Ziprecruiter Inc900.01m64.41m1.80bn1.15k33.7512.0324.132.000.46850.46856.571.311.57--20.38782,619.1011.24--14.61--90.51--7.18----5.810.7834--77.25---96.90------
JOYY Inc (ADR)2.53bn62.96m1.84bn7.45k30.990.353--0.72790.83440.834434.0374.220.2806--18.67340,197.601.320.89231.901.1433.7031.784.723.29----0.1422223.3336.5416.22-226.31--39.10--
Stagwell Inc2.39bn19.43m1.96bn9.10k270.425.7010.340.81990.02450.024511.921.160.8533--3.77263,118.302.50-1.294.49-2.6136.9634.222.93-1.72--2.010.6037--22.551.1898.48---5.12--
ICF International Inc1.62bn68.73m2.03bn8.00k29.952.4819.391.263.613.6184.8643.540.9293--4.04210,210.803.954.404.955.6936.5036.194.254.25--11.160.354513.993.065.5629.438.837.64--
Goodrx Holdings Inc803.49m-47.11m2.05bn756.00--2.51--2.55-0.115-0.1151.932.060.5055--7.661,062,811.00-2.96---3.11--93.0995.25-5.86-8.62--2.110.4469--35.3649.6391.40------
Sotera Health Co970.81m123.08m2.08bn3.00k16.693.267.602.140.43980.43983.472.250.341211.467.09323,602.004.38--4.61--55.50--12.82--2.535.190.7394--13.85--398.72------
Fate Therapeutics Inc68.26m-253.72m2.13bn449.00--3.65--31.22-2.64-2.640.71056.010.0749--5.83152,020.00-27.84-33.87-31.22-38.24-----371.72-555.43----0.00--77.6666.21-22.36--156.46--
Corecivic Inc1.85bn87.61m2.19bn10.35k12.720.79639.971.180.72250.722515.2811.540.5531--6.66179,069.602.623.002.983.3126.3528.014.735.71--1.260.4926125.86-2.250.1384-195.83---2.85--
EQRx Inc-100.00bn-100.00bn2.21bn242.00--1.45----------3.11----------------------------0.00------59.99------
Yelp Inc1.12bn48.35m2.29bn4.40k51.763.2322.712.050.630.6314.9410.101.05--9.88254,106.104.544.825.405.3391.4593.084.325.72----0.000.0018.207.58304.24---5.33--
IQIYI Inc - ADR4.06bn-499.96m2.38bn5.86k--2.70--0.5856-0.6247-0.62474.941.100.631929.3510.32692,761.40-7.65-19.46-19.07-39.4914.409.42-12.11-27.500.3415-1.550.7395--2.8522.1512.14---41.26--
Data as of Sep 23 2022. Currency figures normalised to Goodrx Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

32.70%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20227.02m8.32%
Light Street Capital Management LLCas of 30 Jun 20224.63m5.49%
Marshall Wace LLPas of 30 Jun 20223.57m4.23%
Renaissance Technologies LLCas of 30 Jun 20223.25m3.85%
Petrus Securities LPas of 30 Jun 20221.80m2.14%
Millennium Management LLCas of 30 Jun 20221.73m2.05%
Two Sigma Investments LPas of 30 Jun 20221.61m1.91%
BlackRock Fund Advisorsas of 30 Jun 20221.47m1.74%
Two Sigma Advisers LPas of 30 Jun 20221.44m1.70%
D. E. Shaw & Co. LPas of 30 Jun 20221.09m1.29%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.